GDC-2394, CAS [[2238822-07-4]]
Artikelnummer:
TGM-T69745
| Artikelname: |
GDC-2394, CAS [[2238822-07-4]] |
| Artikelnummer: |
TGM-T69745 |
| Hersteller Artikelnummer: |
T69745 |
| Alternativnummer: |
TGM-T69745-25MG,TGM-T69745-50MG,TGM-T69745-100MG |
| Hersteller: |
TargetMol |
| Kategorie: |
Biochemikalien |
| GDC-2394, an orally active, selective NLRP3 inhibitor, also targets IL-1beta, exhibiting inhibitory concentrations (IC50s) of 0.4 µM (human IL-1beta) and 0.1 µM (mouse IL-1beta). It effectively hampers NLRP3-induced caspase-1 activity while not affecting NLRC4-dependent inflammasome activation. |
| Molekulargewicht: |
431.51 |
| CAS Nummer: |
[2238822-07-4] |
| Formel: |
C20H25N5O4S |
| Target-Kategorie: |
Others|||NOD-like Receptor (NLR)|||Interleukin|||Caspase |
![]()
|
T69745 |
